Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.
Alleva DG, Maki RA, Putnam AL, Robinson JM, Kipnes MS, Dandona P, Marks JB, Simmons DL, Greenbaum CJ, Jimenez RG, Conlon PJ, Gottlieb PA.
Scand J Immunol. 2006 Jan;63(1):59-69.PMID: 16398702 [PubMed - indexed for MEDLINE]Related articles